HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mason, D. Articles by Zola, H. Search for Related Content PubMed PubMed Citation Articles by Mason, D. Articles by Zola, H.

(Journal of Leukocyte Biology. 2001;70:685-690.)
© 2001 by Society for Leukocyte Biology

CD antigens 2001

David Mason^*, Pascale André, Armand Bensussan, Chris Buckley, Curt Civin^||, Edward Clark^#, Masja de Haas^**, Sanna Goyert, Martin Hadam, Derek Hart, Václav Horejí^&||||&, Stefan Meuer^##, James Morrissey^***, Reinhard Schwartz-Albiez, Stephen Shaw, David Simmons, Mariagrazia Uguccioni^||||||, Ellen van der Schoot^**, Eric Vivier and Heddy Zola^###

^* Haematology Department, John Radcliffe Hospital, Oxford,
Division of Immunity and Infection, MRC Centre for Immune Regulation, Birmingham, and
^&& Celltech R&D Ltd., Great Abington, Cambridge, United Kingdom;
Centre d’Immunologie, INSERM-CNRS de Marseille Luminy, Marseille, and
INSERM Institut National de la Santé et de la Recherche Medicale, Creteil, France;
^|| Johns Hopkins Comprehensive Cancer Center, Baltimore, Maryland;
^# Department of Microbiology, University of Washington, Seattle;
^** Central Laboratory of the Netherlands, Department of Experimental Immunohematology, Amsterdam, The Netherlands;
Laboratory of Molecular Hematology/Division of Molecular Medicine, Cornell University Medical College, Manhasset, New York;
Kinderklinik-Medizinische Hochschule, Hannover, and
^## Institut für Immunologie, Ruprecht-Karls Universität and
German Cancer Research Centre, Tumor Immunology, Heidelberg, Germany;
Mater Medical Research Institute, Mater Hospital, South Brisbane, and
^### Child Health Research Institute, Women’s & Children’s Hospital, North Adelaide, SA, Australia;
^|||| Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic;
^*** University of Illinois College of Medicine, Urbana;
National Institute of Health, Bethesda, Maryland; and
^|||||| Institute for Research in Biomedicine, Bellinzona, Switzerland

Correspondence: Prof. David Y. Mason, Haematology Department, John Radcliffe Hospital, Oxford OX3 9DU, U.K. E-mail: david.mason{at}ndcls.ox.ac.uk

This paper reviews the Seventh Human Leucocyte Differentiation Antigen (HLDA7) workshop. Due to the limitations of "blind" antibody screening, which had been evident at the previous meeting in 1996, participants at HLDA7 adopted a more selective approach to the choice of antibodies by identifying new CD specificities. This resulted in the addition of more than 80 new CD specificities. Plans for the eighth and subsequent workshops are also previewed.

Key Words: HLDA workshops • leukocyte molecules